(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 110.95%4.27K | 25.49%-716 | -871.84%-51.04K | -865.39%-6.59K | -353.35%-4.5K | -6,875.49%-38.99K | 86.89%-961 | 99.80%-5.25K | 100.10%861 | 100.22%1.78K |
Net income from continuing operations | 51.65%-35.33K | 84.43%-13.87K | 81.16%-212.39K | 91.98%-71.49K | 108.14%21.24K | -145.30%-73.07K | 34.47%-89.07K | -115.15%-1.13M | -109.09%-891.8K | 66.99%-260.89K |
Operating gains losses | --0 | -323.08%-609 | 99.84%-132 | 502.29%17.66K | 62.43%-7.89K | 54.33%-10.17K | 100.63%273 | 99.22%-83.61K | 100.03%2.93K | ---21K |
Unrealized gains and losses of investment securities | -78.73%12.46K | -96.32%3.09K | -64.15%143.47K | -91.80%38.05K | -115.95%-37.13K | 123.73%58.6K | 270.25%83.95K | 169.43%400.18K | 180.45%463.74K | --232.71K |
Remuneration paid in stock | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 3.43%340.57K | 56.27%310.15K | --3.96K |
Other non cashItems | --2.39K | --2.39K | ---11.4K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Change In working capital | 272.29%24.74K | 112.58%8.28K | -93.67%29.41K | -82.22%20.59K | -58.98%19.28K | -114.31%-14.36K | -98.07%3.89K | -50.38%464.92K | -84.05%115.83K | --46.99K |
-Change in receivables | -17.24%-1.9K | -115.38%-484 | -98.93%851 | -106.84%-2.56K | 183.82%1.88K | 68.39%-1.62K | -93.66%3.15K | 616.68%79.63K | 262.23%37.4K | ---2.24K |
-Change in prepaid assets | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 200.00%6.25K | --0 | -162.51%-245.12K |
-Change in payables and accrued expense | 309.06%26.63K | 1,071.39%8.76K | -92.47%28.56K | -70.49%23.15K | -94.09%17.4K | -609.60%-12.74K | -80.05%748 | -60.46%379.04K | -92.43%78.44K | 175.07%294.36K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 110.95%4.27K | 25.49%-716 | -871.84%-51.04K | -865.39%-6.59K | -353.35%-4.5K | -6,875.49%-38.99K | 86.89%-961 | 99.35%-5.25K | -99.91%861 | 100.22%1.78K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Cash from discontinued investing activities | ||||||||||
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 48K | 0 | 0 | 0 | 0 | 0 | ||||
Net issuance payments of debt | ---- | ---- | --48K | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | --48K | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | -88.90%456 | -87.48%1.17K | -56.12%4.11K | 135.86%7.66K | 726.17%12.15K | 102.32%4.11K | 0.00%9.36K | -91.18%9.36K | 100.65%3.25K | -99.50%1.47K |
Current changes in cash | -85.80%1.89K | 86.37%-716 | 42.10%-3.04K | -865.39%-6.59K | -353.35%-4.5K | 2,478.89%13.3K | 28.34%-5.25K | 94.57%-5.25K | -99.83%861 | 100.22%1.78K |
Effect of exchange rate changes | ---- | ---- | --106 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
End cash Position | -61.13%4.72K | -88.90%456 | -71.46%1.17K | -71.46%1.17K | 135.86%7.66K | 726.17%12.15K | 102.32%4.11K | -56.12%4.11K | -56.12%4.11K | 100.65%3.25K |
Free cash from | 110.95%4.27K | 25.49%-716 | -871.84%-51.04K | -865.39%-6.59K | -353.35%-4.5K | -6,875.49%-38.99K | 86.89%-961 | 99.35%-5.25K | -99.91%861 | 100.22%1.78K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data